文献速递糖尿病

1型糖尿病中估算肾小球滤过率的早期轨迹与长期晚期肾脏及心血管并发症

Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2022-01-01

本研究基于糖尿病控制与并发症试验(DCCT)中1441例1型糖尿病患者平均6.5年的eGFR年变化率,按是否存在早期eGFR快速下降(斜率≤-3%/年)分组,随访DCCT结束后24年。结果显示早期快速eGFR下降与eGFR降低风险相关(HR 1.81,95%CI 1.18-2.79,P=0.0064),但校正基线eGFR后关联消失(HR 0.94,95%CI 0.53-1.66,P=0.84),与复合心血管事件或MACE无关联。

要点

  • DCCT期间1441例1型糖尿病患者中149例(10.4%)出现早期eGFR快速下降(斜率≤-3%/年)。
  • 早期快速eGFR下降与eGFR降低风险相关(HR 1.81,95%CI 1.18-2.79,P=0.0064)。
  • 校正基线eGFR后该关联消失(HR 0.94,95%CI 0.53-1.66,P=0.84),与心血管事件无关联。

核心结论

  • 在eGFR主要为正常且白蛋白尿正常的1型糖尿病患者中,既往eGFR斜率在已知个体当前eGFR水平之外,对肾脏或心血管结局不提供额外关联。

研究设计与样本

  • 基于糖尿病控制与并发症试验(DCCT)1441例参与者的分析,计算平均6.5年期间eGFR年百分比变化(斜率),按有无早期快速eGFR下降(斜率≤-3%/年)二分类,随访DCCT结束后24年。

主要发现

  • DCCT结束时糖尿病病程12±4.8年,85.9%的参与者为白蛋白尿正常,平均eGFR为117.0±13.4 mL/min/1.73 m2,149例(10.4%)在此前试验阶段出现早期快速eGFR下降。
  • 随后24年随访期间发生187例eGFR降低事件(6.3/1000人年)和113例MACE事件(3.6/1000人年)。
  • 早期快速eGFR下降与eGFR降低风险相关(HR 1.81,95%CI 1.18-2.79,P=0.0064),但校正基线eGFR水平后无关联(HR 0.94,95%CI 0.53-1.66,P=0.84)。
  • 与复合心血管事件或MACE无关联。

关键数值与推荐

  • 早期快速eGFR下降定义为eGFR年百分比变化斜率≤-3%/年。
  • 结局指标包括eGFR降低(eGFR<60 mL/min/1.73 m2)、复合心血管事件或主要不良心血管事件(MACE)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rapid loss of estimated glomerular filtration rate (eGFR) within its normal range has been proposed as a strong predictor of future kidney disease. We investigated this association of eGFR slope early in the course of type 1 diabetes with long-term incidence of kidney and cardiovascular complications. RESEARCH DESIGN AND METHODS: The annual percentage change in eGFR (slope) was calculated during the Diabetes Control and Complications Trial (DCCT) for each of 1,441 participants over a mean of 6.5 years and dichotomized by the presence or absence of early rapid eGFR loss (slope ≤-3% per year) as the exposure of interest. Outcomes were incident reduced eGFR (eGFR <60 mL/min/1.73 m2), composite cardiovascular events, or major adverse cardiovascular events (MACE) during the subsequent 24 years post-DCCT closeout follow-up. RESULTS: At DCCT closeout (the baseline for this analysis), diabetes duration was 12 ± 4.8 years, most participants (85.9%) had normoalbuminuria, mean eGFR was 117.0 ± 13.4 mL/min/1.73 m2, and 149 (10.4%) had experienced early rapid eGFR loss over the preceding trial phase. Over the 24-year subsequent follow-up, there were 187 reduced eGFR (6.3 per 1,000 person-years) and 113 MACE (3.6 per 1,000 person-years) events. Early rapid eGFR loss was associated with risk of reduced eGFR (hazard ratio [HR] 1.81, 95% CI 1.18-2.79, P = 0.0064), but not after adjustment for baseline eGFR level (HR 0.94, 95% CI 0.53-1.66, P = 0.84). There was no association with composite cardiovascular events or MACE. CONCLUSIONS: In people with type 1 diabetes primarily with normal eGFR and normoalbuminuria, the preceding slope of eGFR confers no additional association with kidney or cardiovascular outcomes beyond knowledge of an individual's current level.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Perkins BA, Bebu I, Gao X, et al. Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes. Diabetes Care. 2022. PMID: 35015817. doi:10.2337/dc21-1883

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。